Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
ConditionSolid Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12+
SponsorNational Cancer Centre, Singapore
About this trial
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed histological diagnosis of solid tumor
Suitable for systematic treatment and clinical trials
ECOG (Eastern cooperative oncology group) performance status < 2
Able to provide tumor tissue for molecular profiling
Disqualifiers
None
Trial population
Any advanced cancer patient who would benefit from molecular profiling and is a potential clinical trial candidate as identified by treating physician.
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
5,500 Participants
are grouped into 1 trial groupGroup A: tumor tissue for molecular profiling
Trial outcomes
Primary outcomes
1
The molecular and clinical epidemiology for cancer patients being considered for novel therapeutics
Time frame
5 yearsSecondary outcomes
1
The proportion of patients who have actionable alterations and enrol into clinical trials
Time frame
5 years2
The correlation of molecular profiles with clinical outcomes
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov